Holocene Advisors’s AstraZeneca AZN Stock Holding History

Holocene Advisors’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-791,500	Closed	-$107M	–	703
2023 Q3	$107M	Buy	791,500 +43,500	+6%	+$5.94M	0.47%	65
2023 Q2	$107M	Buy	748,000 +186,600	+33%	+$27.5M	0.46%	75
2023 Q1	$77.9M	Buy	+561,400	New	+$75.5M	0.38%	86
2021 Q3	–	Sell	-306,250	Closed	-$36.7M	–	807
2021 Q2	$36.7M	Buy	+306,250	New	+$33.6M	0.21%	147
2020 Q3	–	Sell	-158,150	Closed	-$16.7M	–	672
2020 Q2	$16.7M	Buy	+158,150	New	+$16.3M	0.15%	163

Other funds holding AZN

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

VAM

Vanguard Asset Management London, Ec4n 8af $117B AUM

Holocene Advisors's AZN Position: Q1 2026 in Review

Holocene Advisors increased its AstraZeneca (AZN) stake by 23% in Q1 2026, buying an estimated $95.8M and bringing the position to 2,662,887 shares worth $525M. The position accounts for 1.27% of the portfolio, ranked #10.

Holocene Advisors first reported a position in AZN in Q2 2019 and has held it in 22 quarters since. 1,379 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

Holocene Advisors held 2,662,887 shares of AstraZeneca worth $525M as of Q1 2026.
Holocene Advisors bought 496,825 AstraZeneca shares in Q1 2026, an estimated $95.8M.
AstraZeneca made up 1.27% of Holocene Advisors's portfolio in Q1 2026, its #10 holding.
Holocene Advisors first reported a position in AstraZeneca in Q2 2019 and has held it in 22 quarters since.
1,379 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Holocene Advisors's 13F filing for Q1 2026, filed 15 May 2026.